Home » Trials


Trials

 

Trial Title Registration Number Flag

Acute effects of L-theanine and caffeine combination on selective attention in adolescents with attention deficit hyperactivity disorder

SLCTR/2023/004

Efficacy, safety and cost-effectiveness of Atorvastatin 40 mg versus 80 mg in South Asians with Acute Coronary Syndrome: A Randomized Controlled Trial

SLCTR/2023/003

A Phase II/III randomized, controlled, open labelled study to evaluate the safety and efficacy of snake venom antiserum – Sri Lanka (SL-AVS) developed for Sri Lankan species vs currently used anti snake venom.

SLCTR/2023/002

Open-Label, Randomized Controlled Trial to Investigate Outcome of a Pain Coping Skills Psychological Intervention in Relieving Pain and Psychological Distress in Sinhala-conversant Patients with Chronic Knee Osteoarthritis

SLCTR/2023/001

Determination of the effects of herbal tea made of Osbeckia octandra on hepatic steatosis in metabolic dysfunction associated fatty liver disease.

SLCTR/2022/030

“Vivesa”: Let’s read storybooks - Evaluating the effectiveness of an online, self-paced training intervention for Sinhala speaking parents of children with complex communication needs: A pilot study

SLCTR/2022/029

Phase 2/3, Multicenter, Open-label Trial to Evaluate the Long-term Safety, Tolerability, and Efficacy of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy

SLCTR/2022/028

A Pilot Study To Inform A 3-Arm Parallel-Group RCT Of An Adapted Brief Intervention For Alcohol Use Disorders In Sri Lanka, And Assess Potential Correlates Of Effectiveness, Such As Early Childhood Trauma

SLCTR/2022/027

“Cultivating a Green Lifestyle (CGL)” intervention to promote low carbon lifestyles and enhanced perceived quality of life among Sinhala-speaking private sector employees in Western province, Sri Lanka: A Randomized Controlled Trial

SLCTR/2022/026

Dose-ranging Study of Link Natural Swastha Amurtha (LNSA) in post-adolescent volunteers suffering from mild to moderate facial acne: a Randomized, Double-blind, Placebo-controlled, Phase-2 Study

SLCTR/2022/025

- Protocol changed - Trial completed - Progress reports not updated - Retrospective trial - Duplicate registration